SFE Investment Counsel’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.77M Buy
48,837
+5,726
+13% +$661K 0.78% 52
2026
Q1
$5.15M Sell
43,111
-309
-0.7% -$40.5K 0.81% 51
2025
Q4
$5.91M Buy
43,420
+88
+0.2% +$12.7K 0.91% 42
2025
Q3
$6.39M Buy
43,332
+382
+0.9% +$53K 1.02% 34
2025
Q2
$5.56M Sell
42,950
-9
-0% -$1.09K 0.98% 37
2025
Q1
$5.13M Buy
42,959
+15,199
+55% +$1.88M 1.03% 38
2024
Q4
$3.22M Buy
27,760
+9,010
+48% +$1.14M 0.68% 53
2024
Q3
$2.53M Buy
18,750
+3,450
+23% +$462K 0.53% 61
2024
Q2
$2.08M Sell
15,300
-190
-1% -$25.8K 0.46% 64
2024
Q1
$2M Buy
15,490
+130
+0.8% +$15.7K 0.45% 67
2023
Q4
$1.76M Buy
15,360
+4,980
+48% +$497K 0.46% 66
2023
Q3
$945K Buy
+10,380
New +$1.07M 0.27% 77

Other funds holding XYL

SFE Investment Counsel's XYL Position: Q2 2026 in Review

SFE Investment Counsel increased its Xylem (XYL) stake by 13% in Q2 2026, buying an estimated $661K and bringing the position to 48,837 shares worth $5.77M. The position accounts for 0.78% of the portfolio, ranked #52.

SFE Investment Counsel first reported a position in XYL in Q3 2023 and has held it in 12 quarters since. The position peaked at $6.39M in Q3 2025. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • SFE Investment Counsel held 48,837 shares of Xylem worth $5.77M as of Q2 2026.
  • SFE Investment Counsel bought 5,726 Xylem shares in Q2 2026, an estimated $661K.
  • Xylem made up 0.78% of SFE Investment Counsel's portfolio in Q2 2026, its #52 holding.
  • SFE Investment Counsel first reported a position in Xylem in Q3 2023 and has held it in 12 quarters since.
  • SFE Investment Counsel's Xylem position peaked at $6.39M in Q3 2025.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on SFE Investment Counsel's 13F filing for Q2 2026, filed 5 Aug 2026.